MADELYNN RANDALL: Open Payments
NPI 1700660065 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 11 payments from 5 companies in 2025. Trend: 2023 $169 · 2024 $1,227 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Boston Scientific Corporation | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| SI-BONE, INC. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: Belbuca, QULIPTA, BOTOX, General - Pain Management, Intracept, General - Therapies, UBRELVY, HORIZANT.
Industry payments across UT — which companies pay providers there.
